Telecoms Today
SEE OTHER BRANDS

Catch up with telecommunications news from the world

Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on July 29, 2025

DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results

DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results

Châtillon, France, July 29, 2025 DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, …

DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025

DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025

Châtillon, France, le 29 juillet 2025 DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT-CUSIP : 23306J309), société biopharmaceutique …

Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004)

Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004)

– Trial demonstrates 49% confirmed ORR in the 30mg onvansertib dose arm versus 30% confirmed ORR in the control arm in intent-to-treat population (N=110) – – Early PFS data show a trend favoring 30mg onvansertib dose arm vs. control arm – – Onvansertib …

Landstar System Reports Second Quarter Revenue of $1.211b and Earnings Per Share of $1.20

Landstar System Reports Second Quarter Revenue of $1.211b and Earnings Per Share of $1.20

JACKSONVILLE, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- Landstar System, Inc. (NASDAQ: LSTR) (“Landstar” or the “Company”) today reported basic and diluted earnings per share (“EPS”) of $1.20 in the 2025 second quarter on revenue of $1.211 billion. “The …

Mondelēz International Reports Q2 2025 Results

Mondelēz International Reports Q2 2025 Results

Second Quarter Highlights1 Net Revenues +7.7%, Organic Net Revenues +5.6%, Volume/Mix -1.5% Diluted EPS increased 8.9% to $0.49 Adjusted EPS was $0.73 which declined 14.5% on a constant currency basis Year-to-date cash provided by operating activities was …

Orion Group Holdings Reports Second Quarter 2025 Results and Reaffirms Fiscal Year 2025 Guidance

Orion Group Holdings Reports Second Quarter 2025 Results and Reaffirms Fiscal Year 2025 Guidance

HOUSTON, July 29, 2025 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”, “Orion”), a leading specialty construction company, today reported its financial results for the second quarter ended June 30, 2025. Highlights for the …

Teladoc Health Reports Second Quarter 2025 Results

Teladoc Health Reports Second Quarter 2025 Results

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended June 30, 2025 (“Second Quarter 2025”). Unless otherwise noted, percentage and …

Myriad Genetics to Release Second Quarter 2025 Financial Results on August 5, 2025

Myriad Genetics to Release Second Quarter 2025 Financial Results on August 5, 2025

SALT LAKE CITY, July 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its second quarter 2025 earnings conference call at 4:30pm ET on Tuesday, Aug. 5, 2025. The …

LifeMD to Report Second Quarter 2025 Financial Results on August 5

LifeMD to Report Second Quarter 2025 Financial Results on August 5

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2025 after the close of the U.S. …

NeuroPace to Report Second Quarter 2025 Financial Results on August 12, 2025

NeuroPace to Report Second Quarter 2025 Financial Results on August 12, 2025

MOUNTAIN VIEW, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the second quarter of …

Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference

Pulmonx to Present at the Canaccord Genuity 45th Annual Growth Conference

REDWOOD CITY, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the company will be presenting at the Canaccord …

Viasat Sets August 5, 2025 for First Quarter Fiscal Year 2026 Financial Results Conference Call and Webcast

Viasat Sets August 5, 2025 for First Quarter Fiscal Year 2026 Financial Results Conference Call and Webcast

CARLSBAD, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications, today announced it will release its first quarter fiscal year 2026 financial results on Tuesday, August 5, 2025 after the market …

Varonis Announces Second Quarter 2025 Financial Results

Varonis Announces Second Quarter 2025 Financial Results

Annual recurring revenues grew 19% year-over-year SaaS ARR as a percentage of total ARR was approximately 69% Year-to-date cash from operations generated $89.3 million vs. $68.4 million last year Year-to-date free cash flow generated $82.7 million vs. $67. …

Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025

Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025

MOUNTAIN VIEW, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal …

Safe Bulkers, Inc. Reports Second Quarter 2025 Results and  Declares Dividend on Common Stock

Safe Bulkers, Inc. Reports Second Quarter 2025 Results and Declares Dividend on Common Stock

MONACO, July 29, 2025 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (the "Company") (NYSE: SB), an international provider of marine drybulk transportation services, announced today its unaudited financial results for the three and six-month periods ended June 30, …

Cardiff Oncology Reports Second Quarter 2025 Results and Provides Business Update

Cardiff Oncology Reports Second Quarter 2025 Results and Provides Business Update

- Appointed Dr. Roger Sidhu as Chief Medical Officer - - Completed enrollment in randomized Phase 2 CRDF-004 trial evaluating onvansertib + standard of care for the treatment of first-line RAS-mutated metastatic colorectal cancer (“mCRC”) - - Announced …

Expand Energy Corporation Reports Second Quarter 2025 Results

Expand Energy Corporation Reports Second Quarter 2025 Results

OKLAHOMA CITY, July 29, 2025 (GLOBE NEWSWIRE) -- Expand Energy Corporation (NASDAQ: EXE) (“Expand Energy” or the “Company”) today reported second quarter 2025 financial and operating results. Net cash provided by operating activities of $1,322 million Net …

EXL announces $125 million accelerated share repurchase program

EXL announces $125 million accelerated share repurchase program

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a global data and AI company, today announced that, as part of its capital allocation program, it has entered into an accelerated share repurchase agreement (the “ASR”) with Citibank, N.A. to …

Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance

Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance

IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended June 30, 2025 and raised its …

Larimar Therapeutics Announces Proposed Underwritten Public Offering

Larimar Therapeutics Announces Proposed Underwritten Public Offering

BALA CYNWYD, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that it has commenced an …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions